Inventor

Dietmar Zdunek

Inventor
Tutzing, DE

Overview

25→
Patents
1992–2021
Patent span
Physics
Primary field (CPC G)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties62%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
Y10TTechnical subjects covered by former us classification5%
A61KPreparations for medical, dental or toiletry purposes3%
C07HSugars3%
C07KPeptides3%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
11,047,865Troponin and BNP based diagnosis of risk patients and cause of stroke202111,016,102Troponin and BNP based diagnosis of risk patients and cause of stroke202110,942,175Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure202110,732,188NT-proANP and NT-proBNP for the diagnosis of stroke20209,983,213Identification of subjects being susceptible to anti-angiogenesis therapy20189,638,700'NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events'20179,535,073'Prediction and recognition of acute kidney injury after surgery'20178,771,961'Monitoring myocardial infarction and its treatment'20148,663,941'Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction'20148,501,155'Biochemical markers for acute pulmonary embolism'20138,497,095'Biochemical markers for acute pulmonary embolism'20138,486,706'L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy'20138,440,463'Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1'20138,361,800'Diagnostic means and methods using troponin T and NT-proBNP'20138,062,857'H-FABP as early predictor of myocardial infarction'20118,008,083'Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization'20118,003,396'NT-proBNP/troponin ratio for assessing myocardial dysfunction'20117,977,105'Myoglobin as early predictor of myocardial infarction'20117,955,854'Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides'20117,651,679'Biochemical markers for acute pulmonary embolism'20105,858,803'Process and reagent for the determination of a specifically bindable substance'19995,362,655'Process for the determination of a specifically bindable substance'19945,254,677'.beta.-galactosidase substrates for cedia'19935,219,764'Hapten-biotin conjugates and their use'19935,164,321'Process for the removal of non-specific turbidities'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–1999Based in Munich, DE· patent location history
1994Based in Muchen, DE· patent location history
2010–2014Patents assigned to ROCHE DIAGNOSTICS OPERATIONS (13)· patent assignee history
2010–2013Based in Tutzingen, DE· patent location history
2011–2018Patents assigned to HESS GEORG (10)· patent assignee history
2011–2018Patents assigned to ZDUNEK DIETMAR (10)· patent assignee history
2011–2021Based in Tutzing, DE· patent location history
2013–2018Patents assigned to HORSCH ANDREA (9)· patent assignee history
2017–2021Patents assigned to ROCHE DIAGNOSTICS OPERATIONS INC (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ROCHE DIAGNOSTICS OPERATIONS132010–2014
HESS GEORG102011–2018
ZDUNEK DIETMARself102011–2018
HORSCH ANDREA92013–2018
ROCHE DIAGNOSTICS OPERATIONS INC62017–2021
Locations
LocationPatentsSpan
Tutzing, DE172011–2021
Munich, DE41992–1999
Tutzingen, DE32010–2013
Muchen, DE11994